Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utility of Quantitative Imaging Parameters from Deep Learning-based CT Segmentation in Assessing Hepatic Steatosis and Fibrosis in Chronic Hepatitis B: a Prospective Study Using MRI As the Reference Standard

NCT06616103 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT06616103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06616103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utility of Quantitative Imaging Parameters from Deep Learning-based CT Segmentation in Assessing Hepatic Steatosis and Fibrosis in Chronic Hepatitis B: a Prospective Study Using MRI As the Reference Standard
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
September 26, 2024
Completion date
August 31, 2025
Enrollment
111 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b, fibrosis and cirrhosis of liver, steatosis of liver